News

Pulmonology Advisor1d
Atrial Fibrillation Linked to Risk for Incident Pulmonary Hypertension
There is increased risk for pulmonary hypertension in patients with both atrial fibrillation and incident venous thromboembolism.
MedTech Intelligence1d
Boston Sci receives FDA approval for expanded labeling of FARAPULSE™
The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial ...
TMCnet2d
First Patients Enrolled in IMPRoVED-AF Study Using vMap, a Non-Invasive ECG-Based Tool Designed to Guide More Effective AF Ablation
Vektor Medical, a medical technology company transforming standard ECG data into actionable insights that guide arrhythmia ...
MedTech Dive3d
Boston Scientific gets expanded PFA label for persistent AFib
Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible ...
Boston Scientific Corporation: Boston Scientific receives FDA approval for expanded labeling of FARAPULSE Pulsed Field Ablation System
The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial fibrillation MARLBOROUGH, Mass., July 7, ...